ReviewActa pharmaceutica Sinica. B2021

Gains from no real PAINS: Where 'Fair Trial Strategy' stands in the development of multi-target ligands.

Jianbo Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.